NIBR Global Scholars Program

The NIBR Global Scholars Program (NGSP) is a competitive program designed for innovators from invited institutions to gain funding for breakthrough science not covered by traditional grant support. Through this program, NIBR supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research.

Curve of life world image

In 2020, 38 institutions from nine countries were invited to participate. Novartis scientists evaluated proposals and selected six investigators and their innovative projects that push scientific boundaries.

Meet the 2020 recipients

We are honored to welcome the following innovators to the inaugural NIBR Global Scholars Program. Each Scholar will receive up to 1 mil USD funding over the next three years along with drug-hunting expertise from a dedicated NIBR scientific collaborator. Together with these distinguished Scholars, we will explore new scientific frontiers in our shared mission to improve the lives of patients.

Access to inter-disciplinary expertise

Academic scholars have access to disease area drug-hunting and translational research expertise. Each selected scholar will join forces with other entrepreneurially motivated NIBR scientists to challenge the status quo and take bold risks for potential big rewards, and will have an opportunity to advance research into early development stages.

Resources for breakthrough science

In addition to the funding of USD 1M over three years, a dedicated alliance manager will ensure a productive collaboration environment between NIBR and the academic institution by handling all operational facets of the NGSP.

38 premier institutions around the world are participating
University of Vienna AT Imperial College London UK
Monash University AU University of Oxford UK
University of Queensland AU Boston University US
University of Melbourne AU Brigham and Women’s Hospital US
Walter & Eliza Hall Inst. AU City of Hope US
Hospital for Sick Children (U Toronto) CA Columbia University US
Sinai Health System / Lunenfeld (U Toronto) CA Dana-Farber Cancer Research Institute US
Sunnybrook Research Institute (U Toronto) CA Fred Hutchinson Cancer Research Center US
University of Toronto CA Mass General Hospital US
University of Zurich CH Mass Eye and Ear (MEEI) US
University of Basel CH McLean Hospital US
ETH Zurich CH Schepens Eye Research Institute (SERI) US
LMU Munich DE UC Berkeley US
Universität Freiburg, Medizinische Fakultät DE UC San Diego US
Osaka University JP UC San Francisco US
University of Tokyo JP University of Florida US
Kyoto University JP UMass Medical School US
Asan Medical Center KR University of Michigan US
Seoul National University Hospital KR Weill Cornell US